HomeAbout Us Executive Committee

Executive Committee
2017 - 2018

Officers

  • President

    Christopher Paul Evans, MD, FACS Show More
    University of California, Davis
    Department of Urology
    4860 Y Street
    Suite 3500
    Sacramento, CA 95817
    Christopher P. Evans, MD, FACS

    Dr. Evans is professor and chairman of the Department of Urology at University of California, Davis School of Medicine and a member of the UC Davis Cancer Center. Dr. Evans attended Dartmouth Medical School on a Health Professional Services Program scholarship and he served on active duty in the United States Army, including two years as Chief of Experimental Surgery at the Walter Reed Army Institute of Research. He completed surgery and urology training at the University of California, San Francisco where he was also a National Kidney Foundation Scholar. Dr. Evans completed fellowship training in urologic oncology at the University of Texas, MD Anderson Cancer Center. He came to UC Davis in 1997 at which time he was also Director of Urology Research. In 2006, Dr. Evans became Department Chairman, and in 2010 he became Chairman of the UC Davis Medical Group Practice Management Board. Dr. Evans’ practice is dedicated to the management of patients with urologic malignancies. He works with medical oncologists and radiation oncologists to provide multimodal approaches to cancer therapy.

    Dr. Evans’ research laboratory focuses on prostate cancer; specifically, mechanisms signaling the androgen receptor to activate prostate cancer growth and progression following castration. His laboratory has developed models to study this and has identified novel mechanisms that activate the androgen receptor. His laboratory work has tested new agents and brought them from bench studies to animal models to clinical trials.

    Dr. Evans is president-elect of the Society of Urologic Oncology and is Chair of the ASCO-GU Steering Committee. He is also an elected member of the American Association of Genitourinary Surgeons. His research laboratory has received funding from the National Institute of Health, Department Of Defense, New York Academy of Medicine, Prostate Cancer Foundation, and the American Cancer Society. He has published over 125 peer-reviewed articles.
  • President-Elect

    Michael S. Cookson, MD, MMHC Show More
    University of Oklahoma
    Health Sciences Center
    920 Stanton L. Young Blvd.
    WP3150
    Oklahoma City, OK 73104
    Michael S. Cookson, MD

    Michael S. Cookson, MD is Professor and Chairman of the Department of Urology at the University of Oklahoma Health Sciences Center, and holds the Donald D. Albers Endowed Chair in Urology. An accomplished researcher and lecturer, he is the author of 206 peer-reviewed journal publications and 28 chapters of various textbooks in urology and urologic surgery, and has been recognized nationally for his outstanding contributions to urologic oncology.

    Dr. Cookson completed his Urology residency at the University of Texas, San Antonio and completed his Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. He was a member of the faculty at Vanderbilt University from 1998 to 2013, where he served as the Vice Chairman of Urologic Surgery and Director of the Urologic Oncology Fellowship Program.

    Dr. Cookson has devoted a significant portion of his academic career to the management of patients with urologic cancers, with a strong emphasis on Clinical Guidelines, Education and Evidenced Based Medicine. He was a member of the AUA/ABU examination committee for 10 years, including a member of Task for Cancer, Oncology Consultant and Pathology editor. He also serves on the ABU Oral Examination Committee. He is a co-founder of the OKAT, an SUO mandated oncology examination that is the standard for benchmarking for members and oncology fellows in training and served as Chair of that OKAT committee for 5 years. In 2011, he received the President’s Distinguished Service Award from the SUO for educational contributions. For his efforts in teaching at Vanderbilt, he was awarded the Michael Rodriquez Award.

    Dr. Cookson recently served as the Chair of the AUA Guidelines Committee on Castration Resistant Prostate Cancer, and has previously served as the member of the AUA Guidelines on localized prostate cancer. He currently serves as Treasurer for the Society of Urologic Oncology.
  • Secretary

    Jeffrey Maxwell Holzbeierlein, MD, FACS Show More
    University of Kansas Medical Center
    3901 Rainbow Blvd.
    MS-3016
    Kansas City, KS 66160
    Jeffrey Holzbeierlein, MD

    Dr. Jeffrey Holzbeierlein is the John W. Weigel Endowed Professor of Urology and the Director of Urologic Oncology at the University of Kansas Medical Center. He was raised in Edmond, Oklahoma and received his undergraduate degree from Vanderbilt University where he played for the men’s tennis team. He received his medical degree from the University of Oklahoma and joined the faculty at KU after completing his internship and residency at Vanderbilt University and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York.

    Dr. Holzbeierlein is a member of the Society of Urologic Oncology where he is the past Chair of the Fellowship Committee and serves on the Executive Board of the SUO. He is the President-Elect of the South Central Section of the American Urological Association and serves on the Board of Directors. He has served on the American Board of Urology Examination Committee and is currently and Oral Examiner for the Board Exams. He is a past Assistant Editor for the Journal of Urology. Dr. Holzbeierein has served on numerous AUA Committees including: the Practice Guidelines Committee and the Public Media Committee and has completed the AUA Leadership Program. In addition, he is a Fellow of the American College of Surgeons and serves on the Kansas selection board. Dr. Holzbeierlein is also the past Chair and founding member of the Young Urologic Oncologists Section of the Society of Urologic Oncology. He is a reviewer for the Journal of Urology, Practical Reviews in Urology, Cancer, and Urologic Oncology. He was recently awarded the Resident Mentoring Award for faculty at the University of Kansas Hospital.

    Dr. Holzbeierlein serves on numerous hospital committees including the University of Kansas Physicians Board of Directors, the Promotions and Tenure Committee, the Elections Committee for the School of Medicine, and the Board for the Kansas Tissue and Serum Repository. He is also co-director of the K-Inbre Translational Research Core, and the Director of the Genitourinary Disease Working Group. He is the Director of the Burns and McDonnell High Risk Prostate Cancer Prevention and Survivorship Clinic at the University of Kansas Cancer Center.

    Dr. Holzbeierlein has published numerous peer reviewed journal articles, and has numerous presentation and abstracts in journals and textbooks dealing with urologic oncology. He has been an annual lecturer for an AUA Course focusing on the Management of High Risk Superficial Bladder Cancer which was selected as one of the “best courses” at the AUA. He has intramural and extramural grant support including a co-investigator on an R01, and as PI on several investigator initiated trials and Pharma trials.

    Dr. Holzbeierlein specializes in the treatment of genitourinary malignancies including prostate, bladder, kidney, testicular, and penile cancers. His research interest includes the androgen receptor as a target of Hsp90 inhibitors in prostate cancer and clinically decreasing the morbidity associated with cystectomy. He lives in Kansas City with his wife Jill and their 4 children, and is civically active at the Hope Lodge of Kansas City and Maisson deNaissance.
  • Treasurer

    Daniel Wei Lin, MD Show More
    University of Washington Medical Center
    Department of Urology
    1959 NE Pacific, BB1106 B
    Campus Box 356510
    Seattle, WA 98195
  • Past President

    Leonard G. Gomella, MD, FACS Show More
    Thomas Jefferson University
    Dept of Urology
    1025 Walnut St.
    Suite 1112
    Philadelphia, PA 19107-5005
    Leonard G. Gomella, MD, FACS

    Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at the Sidney Kimmel Medical College. In 2015 he became President of the Society of Urologic Oncology. Originally from New York, Dr. Gomella completed medical school, general surgery and urology training at the University of Kentucky in Lexington. After a Urologic Oncology Fellowship in the Surgery Branch of the NCI in Bethesda, Maryland, he joined the Jefferson faculty in 1988 and was appointed Chair in 2002. He serves as Senior Director for Clinical Affairs for the Sidney Kimmel Cancer at Jefferson, Clinical Director of the Sidney Kimmel Cancer Center Network and Urology Chair for RTOG (now NRG).

    Dr. Gomella is involved in translational basic science and clinical research in the development of new diagnostic techniques and treatments for prostate, bladder and kidney cancer through the Sidney Kimmel Cancer Center. Dr. Gomella's team was first to use RT-PCR to detect circulating micrometastasis in patients with prostate cancer, a discovery that led to a new field of investigation in this disease. Dr. Gomella is also recognized as an early contributor to urologic laparoscopy, initiating the program at Jefferson in 1990.

    He has given over 500 presentations nationally and internationally and written over 400 papers, chapters and monographs in the field of Urology. He is a consultant to over 2 dozen journals in the field of urology and oncology and in 2010 became Editor-in-Chief of the “Canadian Journal of Urology”.

    Dr. Gomella has authored and edited 63 editions of 17 different books for medical students, residents, and practicing physicians, many of which have been translated into foreign languages. He is the Editor-in-Chief of the “5 Minute Urology Consult” now in its 3rd edition, laparoscopy editor for 2 editions of “Glenn’s Urologic Surgery” and co-author of the "Oxford American Handbook of Urology". "Recovering from Prostate Cancer”, the first book for the public dedicated to prostate cancer, was authored by Dr. Gomella in 1993. In the field of medicine, he is well known for the "Clinician's Pocket Reference", now in its 11th edition, and the annual "Clinician's Pocket Drug Reference" both widely used medical references.

    “Best Doctors in America”, “Top Doctors for Cancer”, Philadelphia Magazine’s “Top Doctors” have recognized him for many years for urologic oncology and prostate cancer including a 2015 national recognition in Newsweek. In 2007, Men’s Health Magazine listed Dr. Gomella as one of the 20 top urologists in the US. Awards have included the American Cancer Society "Volunteer Achievement Award" and an “NCI Achievement Award”. He has been President of the Mid-Atlantic Section of the AUA and elected to the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons. The University of Kentucky College of Medicine awarded him an "Distinguished Alumnus Award” in 2009. In 2015 he received a “Distinguished Contribution Award” from the AUA and from Thomas Jefferson University and Hospital the “Jefferson Achievement Award in Medicine”.

  • Member At Large

    Badrinath R. Konety, MD, MBA Show More
    University of Minnesota
    420 Delaware St. SE
    MMC 394 RM B535
    Minneapolis, MN 55455
  • Member At Large

    Wade Jeffers Sexton, MD Show More
    Moffitt Cancer Center
    12902 Magnolia Dr.
    Tampa, FL 33612
    Wade J. Sexton, MD

    Dr. Sexton attended Furman University in Greenville, South Carolina as a scholar-athlete and graduated with a Bachelor of Science Degree in Biology. While at Furman, he started in the defensive backfield for Furman’s National Championship football team. He attended Emory University’s School of Medicine on an Air Force sponsored Health Professions Scholarship and then completed his general surgery and urology residency training at the Wake Forest University Baptist Medical Center. Following the completion of his residency, Dr. Sexton entered active duty military service with the United States Air Force and while on active duty, was selected to perform a Fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center. From 2001-2004, he served as Director of Urologic Oncology with the 59th Medical Wing at Wilford Hall USAF Medical Center in San Antonio, Texas. Thereafter, he joined the Moffitt Cancer Center in Tampa, Florida, where he is now a Senior Member in the Department of Genitourinary Oncology and a Professor in the Department of Oncologic Sciences with the University of South Florida. Since 2008, he has served as Director of the Society of Urologic Oncology accredited Fellowship at the Moffitt Cancer Center.

    Dr. Sexton has held several leadership positions at Moffitt including an extended service on the Medical Executive Committee culminating as President of the Medical Staff from 2014-2016. He is a 2014 graduate of the inaugural Moffitt Cancer Center Leadership Academy. He has served in different capacities with the Florida Urologic Society including president of the FUS from 2015-2016. He is a long-term member of the NCCN guidelines panel for bladder and penile cancers, a faculty member for the AUA’s Annual Board Review Course (testicular cancer) and a member of the Fellowship Committee for the Society of Urologic Oncology. He is primary investigator and collaborator on numerous clinical trials and grant funded translational studies, has authored over 100 manuscripts and book chapters, and maintains an extremely busy clinical practice focused towards bladder, kidney and testicular malignancies. He was awarded a Meritorious Service Medal while on active duty with the United States Air Force. In 2013, it was a tremendous honor for him to be recognized as an MD Anderson Cancer Center Distinguished Alumnus. He has been recognized as a Top Doctor in Tampa Bay and repeatedly as one of America’s Top Physicians, Top Surgeons and Top Doctors for Cancer.
  • Member At Large

    Edouard John Trabulsi, MD, FACS Show More
    Thomas Jefferson University
    Kimmel Cancer Center
    Department of Urology
    1025 Walnut Street, Suite 1100
    Philadelphia, PA 19107
    Edouard John Trabulsi, MD, FACS

    Dr. Edouard Trabulsi is an Associate Professor and Vice Chair of Regional Outreach in the Department of Urology at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. He received his Bachelor of Science in Biochemistry cum laude with Distinction in Research from the University of Rochester and completed his medical degree magna cum laude at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed surgery internship, surgery residency, and urology residency at Thomas Jefferson University. He also completed fellowships in urologic oncology and minimally invasive urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York. He also completed the Vail ASCO/AACR Methods in Clinical Cancer Research Seminar. He is also a member of Alpha Omega Alpha Medical Honor Society.

    Dr. Trabulsi is Director of the Division of Urologic Oncology in the Department of Urology of Thomas Jefferson University, and Co-Director of the Jefferson Prostate Diagnostic Center at Thomas Jefferson University. He is the Director of Clinical Trials in the Department of Urology and Co-Director of the Genitourinary Oncology Multidisciplinary Cancer Center at the Kimmel Cancer of Thomas Jefferson University. He serves as Cancer Liaison to the American College of Surgeons Commission on Cancer for Thomas Jefferson University Hospital. Regionally, he is section secretary and president-elect of the Mid-Atlantic Section of the American Urological Association; and is President of the Philadelphia Urologic Society.

    Dr. Trabulsi serves on numerous national committees, including the American Urologic Association (AUA) Education Council, the AUA Legislative Affairs Committee, the AUA Urologic Diagnostic and Therapeutic Imaging Committee, and the AUA Bylaws committee. He is a graduate of the AUA Leadership Program. He also serves on the executive committee of the AUA Resident Core Curriculum. Within the ECOG-ACRIN cooperative group, Dr. Trabulsi is co-chair of the Early Modality subcommittee of the GU Core Committee. He was elected to the executive board of the Society of Urologic Oncology. He is a member of the American Urologic Association, the American Society of Clinical Oncology, the American Association of Cancer Research, the Society of Urologic Oncology and the American College of Surgeons.

    Dr. Trabulsi has published numerous manuscripts and book chapters in the field of urologic oncology and prostate cancer imaging. His clinical interests include all areas of urologic oncology and minimally invasive surgery, including prostate cancer, bladder cancer, kidney cancer, testis cancer and penile cancer, as well as robotic and laparoscopic surgery. His research interests include contrast-enhanced transrectal ultrasonography, PET imaging of prostate and bladder cancer, outcomes after robotic prostatectomy, and postoperative radiotherapy after radical prostatectomy. He has been designated as one of America’s “Top Doctors” and “Top Doctors for Cancer” several years running, and has been named as a “Top Doc” by Philadelphia magazine.
  • Winter Scientific Program Co-Chairs

    Christopher Joseph Kane, MD Show More
    UCSD Moores Cancer Center
    200 W Arbor Drive
    MC 8897
    San Diego, CA 92103
  • Winter Scientific Program Co-Chairs

    Bradley C. Leibovich, MD Show More
    Mayo Clinic Rochester
    200 First St., SW
    Rochester, MN 55905-2981
  • Young Urologic Oncologists Representative

    William T. Lowrance, MD, MPH Show More
    Huntsman Cancer Hospital
    Dept. of Urologic Oncology
    1950 Circle of Hope #6405
    Salt Lake City, UT 84112
  • Young Urologic Oncologists Representative

    Matthew Jason Resnick, MD, MPH Show More
    Vanderbilt University
    A-1302 Medical Center North
    Nashville, TN 37232
  • Spring Scientific Program Co-Chairs

    Gennady Bratslavsky, MD Show More
    SUNY Upstate Medical University
    Dept. of Urology
    750 East Adams St.
    Syracuse, NY 13210
  • Spring Scientific Program Co-Chairs

    Marc Arnaldo Dall'Era, MD Show More
    University of California, Davis
    4860 Y Street, Suite 3500
    Sacramento, CA 95817

Standing Committee Chairs

  • AJCC Representative

    Cheryl T. Lee, MD Show More
    Ohio State University
    915 Olentangy River Road
    Suite 3125
    Columbus, OH 43212
    https://wexnermedical.osu.edu/urology
  • Awards Committee Chair

    Leonard G. Gomella, MD, FACS Show More
    Thomas Jefferson University
    Dept of Urology
    1025 Walnut St.
    Suite 1112
    Philadelphia, PA 19107-5005
    Leonard G. Gomella, MD, FACS

    Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at the Sidney Kimmel Medical College. In 2015 he became President of the Society of Urologic Oncology. Originally from New York, Dr. Gomella completed medical school, general surgery and urology training at the University of Kentucky in Lexington. After a Urologic Oncology Fellowship in the Surgery Branch of the NCI in Bethesda, Maryland, he joined the Jefferson faculty in 1988 and was appointed Chair in 2002. He serves as Senior Director for Clinical Affairs for the Sidney Kimmel Cancer at Jefferson, Clinical Director of the Sidney Kimmel Cancer Center Network and Urology Chair for RTOG (now NRG).

    Dr. Gomella is involved in translational basic science and clinical research in the development of new diagnostic techniques and treatments for prostate, bladder and kidney cancer through the Sidney Kimmel Cancer Center. Dr. Gomella's team was first to use RT-PCR to detect circulating micrometastasis in patients with prostate cancer, a discovery that led to a new field of investigation in this disease. Dr. Gomella is also recognized as an early contributor to urologic laparoscopy, initiating the program at Jefferson in 1990.

    He has given over 500 presentations nationally and internationally and written over 400 papers, chapters and monographs in the field of Urology. He is a consultant to over 2 dozen journals in the field of urology and oncology and in 2010 became Editor-in-Chief of the “Canadian Journal of Urology”.

    Dr. Gomella has authored and edited 63 editions of 17 different books for medical students, residents, and practicing physicians, many of which have been translated into foreign languages. He is the Editor-in-Chief of the “5 Minute Urology Consult” now in its 3rd edition, laparoscopy editor for 2 editions of “Glenn’s Urologic Surgery” and co-author of the "Oxford American Handbook of Urology". "Recovering from Prostate Cancer”, the first book for the public dedicated to prostate cancer, was authored by Dr. Gomella in 1993. In the field of medicine, he is well known for the "Clinician's Pocket Reference", now in its 11th edition, and the annual "Clinician's Pocket Drug Reference" both widely used medical references.

    “Best Doctors in America”, “Top Doctors for Cancer”, Philadelphia Magazine’s “Top Doctors” have recognized him for many years for urologic oncology and prostate cancer including a 2015 national recognition in Newsweek. In 2007, Men’s Health Magazine listed Dr. Gomella as one of the 20 top urologists in the US. Awards have included the American Cancer Society "Volunteer Achievement Award" and an “NCI Achievement Award”. He has been President of the Mid-Atlantic Section of the AUA and elected to the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons. The University of Kentucky College of Medicine awarded him an "Distinguished Alumnus Award” in 2009. In 2015 he received a “Distinguished Contribution Award” from the AUA and from Thomas Jefferson University and Hospital the “Jefferson Achievement Award in Medicine”.
  • Bylaws Committee Chair

    Siamak Daneshmand, MD Show More
    University of Southern California-Keck School of Medicine
    1441 Eastlake Ave., Suite 7416
    Los Angeles, CA 90089
    Sia Daneshmand, MD

    Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University and was then recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director.

    Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience with radical cystectomy and continent urinary diversion. His main research interests focus on the use of pathways to improve peri-operative outcomes following radical cystectomy, use of serum and molecular markers and new technologies in diagnosis and management of bladder cancer, as well as functional outcomes following orthotopic urinary diversion. He is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy and his protocol has significantly reduced hospital stay while improving the patient experience. He serves on the editorial board of the Bladder Cancer Journal, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the AUA/SUO Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Cancer Doctors” for numerous consecutive years.

    He is an active member of the Society of Urologic Oncology, has presented over 200 abstracts at scientific meetings and has authored over 180 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.
  • Clinical Trials Committee